Nucleus accumbens-associated protein 1 (NAC1) might have potential oncogenic properties and participate in regulatory networks for pluripotency. Although NAC1 is described as a transcriptional regulator, the nuclear import machinery of NAC1 remains unclear. We found, using a point mutant, that dimer formation was not committed to the nuclear localization of NAC1 and, using deletion mutants, that the amino-terminal half of NAC1 harbored a potential nuclear localization signal (NLS). Wild type, but not mutants of this region, alone was sufficient to drive the importation of green fluorescent protein (GFP) into the nucleus. Bimax1, a synthetic peptide that blocks the importin α/β pathway, impaired nuclear localization of NAC1 in cells. We also used the binding properties of importin to demonstrate that this region is an NLS. Furthermore, the transcriptional regulator function of NAC1 was dependent on its nuclear localization activity in cells. Taken together, these results show that the region with a bipartite motif constitutes a functional nuclear import sequence in NAC1 that is independent of NAC1 dimer formation. The identification of an NAC1 NLS thus clarifies the mechanism through which NAC1 translocates to the nucleus to regulate the transcription of genes involved in oncogenicity and pluripotency.
Introduction
Nucleus accumbens-associated protein 1 (NAC1) has potential oncogenic properties. NAC1 is overexpressed in several types of human carcinomas, including ovarian serous, pancreatic and breast carcinoma (1) . In 20% of ovarian serous carcinomas, the chromosome 19p13.2 NACC1 locus was amplified, leading to NAC1 overexpression (2) . Levels of NAC1 are significantly higher in recurrent chemoresistant ovarian serous carcinomas than in primary untreated tumors (1, 3, 4) . Furthermore, intense NAC1 immunoreactivity in primary ovarian serous carcinomas is associated with early recurrence (2, 5) , suggesting that NAC1 functions in the development of ovarian cancer resistance to chemotherapy. Repressing the transcriptional activity of growth arrest and DNA damage-inducible protein 45 gamma-interacting protein 1 (GADD45GIP1) might contribute to this, at least in part (6, 7) .
Mounting evidence indicates that NAC1 is involved in transcription repression (1, (7) (8) (9) (10) (11) . NAC1 contains an amino-terminal Broad Complex, Tramtrack and Bric à brac (BTB)/Poxvirus and Zinc finger domain and a carboxyl-terminal BANP, E5R and NAC1 (BEN) domain. NAC1 homodimerizes through its BTB domain, in which the interaction interfaces between subunits resembling those in transcription factors that contain BTB (12) . NAC1 lacks a characteristic zinc finger (ZF) or basic leucine-zipper DNA-binding domain and thus differs from most other BTB-domain transcription factors. The BEN domain was identified by computational analysis and it might mediate protein-DNA and protein-protein interactions during chromatin organization and transcription (13) .
NAC1 is a direct binding partner of Nanog, a core factor for the mammalian pluripotency program (14, 15) . NAC1 transcriptionally regulates gene expression of pluripotency factors including Nanog, Oct4 and Sox2, and participates in transcriptional regulatory networks that are critical to establish and/or maintain embryonic stem cell pluripotency (14, 16, 17) .
Materials and methods

Materials
The following commercial antibodies were used: monoclonal anti-FLAG (M2) and anti-β-actin (AC-15) (Sigma, St Louis, MO, USA); anti-mCherry (mC) (Clontech, Mountain View, CA, USA); anti-green fluorescent protein (GFP) (BioAcademia, Osaka, Japan); anti-GADD45GIP1 (Novus Biologicals, Littleton, CO, USA); polyclonal anti-importin α3 and anti-importin α4 (Bethyl Laboratories, Montgomery, TX, USA); anti-GFP (BioAcademia, Osaka, Japan); horseradish peroxidase-HRP-conjugated anti-mouse IgG (Jackson ImmunoResearch Laboratories, West Grove, PA, USA); and Alexa Fluor 488-labeled goat anti-mouse IgG (Molecular Probes, Carlsbad, CA, USA).
Plasmid construction
Fragments of the human NAC1 gene encoding residues 2-527 (full-length, removal of the first methionine), 2-250, 2-129 and 2-125 were cloned into altered version of pMXs, pMXs-FHG that contained Kozak sequence, FLAG-tag, HA-tag and enhanced GFP (EGFP) at 5′ in the multi-cloning sites (BamHI-EcoRI-XhoI-NotI-SalI) by PCR using pCDNA6-V5/NAC1 as template (1) . The gene identification numbers are listed in Supplementary  Table 1 available at Carcinogenesis Online. NAC1 Y86A mutant was created by standard double PCR mutagenesis using the primers NAC1 Y86A-S and Y86A-AS. The primer sequences are listed in Supplementary Table 2 available at Carcinogenesis Online. Human NAC-2 gene was cloned into pMXs-FHG by PCR using IMAGE clone 4654320 as template.
To evaluate the nuclear localization signal (NLS) activity of peptide sequences in mammalian cells, double-stranded oligonucleotides encoding peptides including NAC1 (180-207), NAC1 (170-217), Xenopus nucleoplasmin (155-172) and Bimax1 (RRRRPRKRPLEWDEDEEPPRKRKRLW) were inserted into pMXs-FHG.
The cDNA sequences of the full-length human importin α1, α3, α4 and α6 were PCR amplified using oligo(dT)-primed first-strand cDNAs from human fetal brain (Nippon Gene; Toyama, Japan) (18) . For GST fusions, the importin α1 (70-529), α3 (65-521), α4 (65-521) and α6 (70-539) cDNAs were cloned into pGEX-6P-1 (GE Healthcare, Piscataway, NJ, USA) (19) . Importin α3 mutants at the major NLS binding site (W179A/N183A) were created by standard double PCR mutagenesis using the primers W179A N183A-S and W179A N183A-AS.
For mC fusions, the mC coding region derived from pMXs-mC (20) was cloned into a modified pET-28a (Novagen, Madison, WI, USA) with a hexa-histidine-tag and TEV cleavage site at the amino-terminus and with multi-cloning sites (BamHI-EcoRI-SalI-HindIII-NotI) at the C-terminus, to generate pET28-His-TEV R -mC. Double-stranded oligonucleotides encoding NLS peptides including NAC1 (180-207) and Xenopus nucleoplasmin (155-172) were inserted into pET28-His-TEV
Monoclonal antibody generation
For making the anti-NAC1 mouse monoclonal antibody 9.27, we immunized mice with recombinant GST-tagged full-length NAC1, and serum titers were monitored by immunoblotting using lysates of 293T cells transfected with FLAG-NAC1/pcDNA3. Clonal populations of fusion cells were screened by enzyme-linked immunosorbent assays for antibody production against bacterially expressed hexa-histidine-tagged NAC1. Productive cells were cloned to monoclonal lines by serial dilution screening. Highly concentrated monoclonal antibodies were isolated from murine ascites after an intraperitoneal injection of hybridoma cells.
Cell culture, transfection, and retroviral infection
All adherent cells and hybridomas were grown in Dulbecco's modified Eagle's medium (Nissui, Tokyo, Japan) and RPMI1640 medium, respectively, supplemented with 10% fetal bovine serum (Cell Culture Technologies, Gravesano, Switzerland). All adherent cells were transiently transfected with each plasmid using Lipofectamine 2000 (Invitrogen) according to the manufacturer's instructions. Retrovirus production has been described (20) . Overexpression of NAC1 proteins gives rise to the formation of dense body-like structures in the nucleus (1, 21) . Only GFP-positive cells expressing the lower detectable amounts of fusion protein were isolated by the FACSAris III using FACSDiva software (BD, Franklin Lakes, NJ, USA).
RNA interference and complementation
Stealth small interfering RNA (siRNA) against NAC1 (#1, 5′-CCGGCUGA ACUUAUCAACCAGAUUG-3′; #2, 5′-CAACUUCAAGGAGAGCGAGAU GAAU-3′) were purchased from Invitrogen. siRNA was transfected into cells using Lipofectamine RNAiMAX (Invitrogen) according to the manufacturer's instructions.
The pMXs-IG (22) construct that renders the corresponding NAC1 mRNA insensitive to the siRNA#1 with no effect on the amino acid sequence of expressed NAC1 protein was created by standard double PCR mutagenesis using the primers NAC1-siR-3S and NAC1-siR-4AS.
Immunofluorescence microscopy Cells were simultaneously fixed and permeabilized for 10 min with 3.7% formaldehyde and 0.2% Triton X-100 in PBS, and then washed 3 times with PBS and then blocked for 30 min with 5% skimmed milk in PBS. After the blocking, cells were incubated with primary antibodies for 1 h at room temperature. After four washes with PBS, secondary antibodies incubations were performed for 1 h at room temperature and the coverslips were mounted (mounting medium; Vector Laboratories, Burlingame, CA, USA) with DAPI. Cells were observed under a confocal microscope FV1000 (Olympus, Tokyo, Japan).
To evaluate the NLS activity of Emerald GFP-fused peptides, transfected cells were fixed with 3.7% formaldehyde with/without membrane permeabilization and then the Emerald GFP signals were observed under a confocal microscope FV1000.
Time-lapse recording using confocal microscopy Confocal time-lapse fluorescence images were acquired using an FV1000 laser scanning confocal unit coupled to an inverted microscope (model IX81; Olympus) equipped with a 1.4 NA UPLSAPO 100X oil objective and Fluoview software (Olympus). Cells were maintained at 37°C and analyzed on 35 mm glass-based dishes (IWAKI, Tokyo, Japan) in CO 2 -independent medium (Invitrogen) to avoid medium acidification in the CO 2 -free atmosphere. Using GFP or mC filter sets and DIC optics, 15 optical sections were collected at 1 µm step size every 90 s. Each series was projected onto a single xy-plane. Time-lapse figures and movies were created using Metamorph software (Molecular Devices, Sunnyvale, CA, USA).
Tissue samples and immunohistochemistry
Ovarian cancer patients underwent surgery at the Department of Obstetrics and Gynecology at Shimane University Hospital. Paraffin-embedded tumor tissues were obtained from the Department of Pathology. Diagnosis was based on conventional morphologic examination of hematoxylin-eosin-stained sections. Acquisition of tissue specimens and clinical information was approved by an institutional review board (Shimane University). Immunohistochemistry was done on deparaffinized sections with autoclaving for 10 min. After antigen retrieval in a sodium citrate buffer (pH 6.0), slides were incubated overnight at 4°C with the NAC1 antibodies at a dilution of 1:100 and an EnVision peroxidase kit (DAKO, Glostrup, DK, Denmark). The slides for all the samples were evaluated with a light microscope by two pahologists.
Expression and purification of recombinant proteins
Importins fused with GST were expressed in Escherichia coli BL21 by induction with 0.1 mM IPTG followed by sequential incubation each for 2 h at 37°C. mC proteins fused with various NLS sequences were expressed in BL21(DE3) by induction with 0.1 mM IPTG followed by sequential incubation each for 2 h at 37°C. Purification of proteins was carried out as described previously (23) .
Importin binding assay mC fusion proteins of 2 μg were allowed to bind in extraction buffer to Sepharose-immobilized GST-importin αs at 4°C for 2 h, followed by washing 3 times with the buffer. Sepharose beads were dissolved in 10 μl of 2× Laemmli sample buffer, and the proteins were separated on 10% SDS-PAGE. The gels were stained with Coomassie Brilliant Blue. Bioinformatics NAC1 sequences containing NLS were identified by manually analyzing all entries in the GenBank™ (http://www.ncbi.nlm.nih.gov). Sequences were aligned with CLUSTALW (http://clustalw.ddbj.nig.ac.jp/top-e.html).
Results
Subcellular localization of NAC1
We developed anti-NAC1 monoclonal antibody 9.27 that selectively recognize FLAG-HA-EGFP (FHG) tagged-NAC1 fusion protein expressed in HeLa cells, but not the sole family protein FHG-NAC2 that contains both BTB and BEN domains ( Figure 1A and Supplementary Figure 1 available at Carcinogenesis Online). The antibody detected endogenous NAC1 expression in HeLa cells ( Figure 1B ). As further evidence that the signal reactive with the antibody was authentic NAC1, the antibody failed to detect any bands in NAC1-negative TOV-21G (a human ovarian cancer cell line) and detected a very faint band in NAC1 knockdown HeLa cells ( Figure 1B , middle and right panels). Immunofluorescence or immunohistochemical analysis using the antibody revealed that endogenous NAC1 almost exclusively localized with a fine granular pattern in the nucleus excluding nucleoli in HeLa cells ( Figure 1C ) and cancerous human tissues ( Figure 1D ) as described (6, 9) . Next, we used live-cell imaging to monitor the subcellular distribution of full-length NAC1 fused at the C-terminal to EGFP in HeLa cells ( Figure 1E and Supplementary video 1). During interphase, GFP-NAC1 localized throughout the nucleoplasm. At nuclear envelop breakdown, GFP-NAC1 dispersed throughout the mitotic cytoplasm without specific localization (e.g. in chromosomes or centrosomes). As the nuclear envelope reformed after mitosis, GFP-NAC1 gradually accumulated in the nucleus. These immunofluorescence and time-lapse microscopy studies demonstrate that NAC1 is a nuclear protein.
Nuclear localization signal of NAC1
Nuclear localization lies at the heart of the transcriptional regulator, but the regulation of nuclear NAC1 import is poorly understood. To uncover determinants that are responsible for nuclear NAC1 localization, we generated a series of NAC1 deletion mutants fused with GFP and investigated their subcellular distribution using fluorescence confocal microscopy. HeLa cells express endogenous NAC1 ( Figure 1A -C) and the BTB domain mediates homodimerization (12) . To eliminate the effect of endogenous NAC1 on the subcellular distribution of GFP-tagged exogenous NAC1, we created the point mutation Y86A, in which a conserved tyrosine residue within the BTB domain of NAC1 was replaced with alanine to confer resistance to dimer formation on the basis of structural information and alignment for the BTB domain (12, 24) (Figure 2A and B) .
The transfected cells were fixed with formaldehyde to detect subcellular GFP-tagged NAC1 localization. Under these conditions, GFP was detected exclusively in the cytoplasm, whereas Y86A-based full-length or deletion mutants lacking the carboxyl-terminal half as well as wild-type NAC1 were located in the nucleus ( Figure 2C , panels A-D), indicating that NAC1 dimer formation and the carboxyl-terminal half including the BEN domain are not committed to the nuclear localization of NAC1. In contrast, the ability of other Y86A-based deletion mutants (2-129 and 2-125) to localize in the nucleus was abolished ( Figure 2C , panels E and F), suggesting that residues 130-250 of NAC1 harbor a potential NLS.
We could not identify NLS motifs within NAC1 by a series of computer searches using such tools as PROSITE (http://myhits.
Nuclear localization signal in NAC1
isb-sib.ch/cgi-bin/motif_scan) or MotifScan (http://scansite.mit.edu/ index.html). The classical NLS consists of either one (monopartite) or two (bipartite) stretches of basic amino acids. Visual examination of a cross-species comparison of amino acid sequence alignment of NAC1 revealed two clusters of basic amino acids (KR at one end and RKXAK/R at the other) separated by ~13-21 amino acid linker within the region ( Figure 3A) . To determine whether this region was sufficient to mediate nuclear import, the NAC1 polypeptide (180-207 or 170-217), both comprising the putative NLS of NAC1 (183-205), was appended to GFP (see schematics in Figure 3B 
NAC1 polypeptide (170-217) (data not shown). In contrast, replacing one or both clusters of basic amino acids of the putative NLS motif with alanine residues eliminated nuclear accumulation ( Figure 3B ). Furthermore, mutating the putative NLS motif in wild-type or Y86A-based full-length NAC1 results in failure to localize NAC1 to the nucleus ( Figure 3C ). Thus, these results indicate that NAC1 (180-207) polypeptide functions as potential NLS in cells.
Nuclear translocation of NAC1 involves importins
Because the molecular size of NAC1 (60 kDa) is much larger than the diffusion limit (~50 kDa) of the nuclear pore complex (25), we expected its translocation into the nucleus to be mediated by a carrier-dependent import mechanism. Cargo proteins that contain NLS(s) are recognized, in the cytoplasm, through their NLS(s) by the adaptor proteins termed importins α and/or β, which upon binding the cargo proteins result in a complex that is then ferried through the nuclear pore complex in the nuclear membrane into the nucleoplasm (26, 27) . Bimax1 is a recently developed synthetic peptide that blocks the importin α/β pathway by an extremely high affinity for importin αs (18) .
To assess the impact of Bimax1 on nuclear localization of NAC1, mC-NAC1 expressing HeLa cells were transfected with GFP or GFPBimax1. Live cell microscopic analysis revealed that GFP-Bimax1 impaired nuclear localization of mC-tagged NAC1 in cells that exited from mitosis; it had no effect in cells before nuclear envelope breakdown (Figure 4 , left panels and data not shown), probably due to the absence of capability of Bimax1 to extrude nuclear proteins to cytoplasm and/or the lack of a nuclear export signal in NAC1. Time-lapse imaging clearly confirms the above-mentioned findings (Supplementary Figure 3 and Video 2A and B). As would be predicted, GFP expression alone had no effect even when cells exited from mitosis ( Figure 4 , right panels). Because Bimax1 is a strong and specific binder for the importin α family (18), these results suggest that Bimax1 competed effectively against importin αs for binding to NAC1 that had an intact NLS motif.
Importin binding as evidence for the presence of NLS in NAC1
The human genome encodes seven importin αs that fall into three phylogenetically distinct groups (Supplementary Figure 4A and B) . Human α1, α3 and α6 are representatives of human importin subgroups. In the next approach, we used importin binding properties to demonstrate the presence of NLS in NAC1. We used GST pull-down assays to confirm binding between mC-tagged NAC1 (180-207) and GST-tagged importin α1, α3 and α6 proteins and detected importinbound polypeptides by staining with Coomassie blue ( Figure 5A ). The NAC1 (180-207) polypeptide was preferentially detected in the pulled down complexes associated with importin α3 ( Figure 5A Importin αs contain two NLS binding pockets ( Figure 5E ). To determine whether the binding of NAC1 polypeptide with importin is mediated through these NLS binding pockets, we performed binding assays with a mutated importin α3 in which the major (Trp  179 and  Asn ) stretches of basic amino acids were replaced with Ala separately or together (mut-N, mut-C and mut-N + C, respectively). None of the mutated polypeptides were detected in association with importin α3 ( Figure 5C, lanes 8-10) , confirming that both clusters of basic amino acids of the sequence are essential for binding with importin α3 and that the NLS sequence constitutes a bipartite motif.
Human importin α3 has the closest paralogs of importin α4; it shares 86% identity and 92% similarity with human importin α4 (Supplementary Figure 4A and B available at Carcinogenesis Online). HeLa cells expressed both importin α3 and α4 proteins (Supplementary Figure 5 available at Carcinogenesis Online), consistent with the previous study (28) . We could not express importin α4 in E. coli, thus we expressed importin α3 or α4 fused with GST in 293T cells and purified using glutathione-Sepharose 4B beads. To ascertain whether importin α4 also mediates nuclear import of NAC1, we performed GST pull-down assays to examine binding between GST-tagged importin α4 and mC-tagged NAC1 (180-207) polypeptide. GST-importin α4 as well as α3 could pull-down NAC1 (180-207) peptide ( Figure 5D ).
Thus, we demonstrated that NAC1 has an authentic bipartite nuclear localization sequence through its ability to interact with the importin α3/4 proteins of the nuclear transport machinery.
Mutated NAC1 lacking nuclear localization ability cannot complement for loss of wild-type NAC1
NAC1 represses transcription of the candidate tumor suppressor GADD45GIP1 (6) . To investigate the role of nuclear localization ability of NAC1 in the transcriptional regulator function of NAC1 in HeLa cells, we carried out RNAi complementation experiments. We expressed exogenous NAC1 in HeLa cells. The construct harbored six silent mutations in the siRNA-targeting region that render the corresponding NAC1 mRNA insensitive to the siRNA, denoted (si-R) for resistant hereinafter, but had no effect on the amino acid sequence of expressed NAC1 protein. Immunoblot analysis verified that these constructs were indeed resistant to knock down and that endogenous NAC1 could be efficiently eliminated from cells with NAC1-specific siRNA ( Figure 6A and B) . Using these stable cell lines, we asked whether the exogenously expressed proteins could complement for the loss of endogenous NAC1 by siRNA. As expected, siRNA-mediated knock down of endogenous NAC1 resulted in increased protein level of GADD45GIP1 ( Figure 6A , lane 2). Introduction of a cDNA encoding only wild-type NAC1 (si-R) was sufficient to restore inhibitory function ( Figure 6A, lanes  3 and 4) . By contrast NAC1 mut-c (si-R) lacking nuclear localization ability was not able to complement for loss of endogenous NAC1 expression ( Figure 6A, lanes 5 and 6) . These observations show that nuclear localization ability is essential for the transcriptional regulator function of NAC1 in cells.
Discussion
Large molecules (>50 kDa) cannot passively diffuse through nuclear pores (25) , yet NAC1 with a theoretical molecular weight of 57.3 kDa must be imported into the nucleus through nuclear pores to function as a transcriptional regulator. This study showed that NAC1 harbors Figure 3A) . The central linker region between two basic clusters usually consists of 10-12 amino acids (29) . In this respect, the linkers of the NAC1 family (13-21 amino acids) are atypically long. However, their sequence contexts are glycine-serine rich ( Figure 3A) . Given that the NAC1 linker region is mutation-tolerant (29, 30) , its flexibility might allow significant movement and provide proper spacing between two positively charged clusters. 'Secondly', the sequence must be required for nuclear import. Full-length NAC1 or deletion mutants (2-250) were located in the nucleus ( Figure 2C , panels C and D), whereas NAC1 transport into the nucleus was abolished when the sequence was deleted [deletion mutants (2-129 and 2-125)] ( Figure 2C , panels E and F). 'Thirdly', the sequence must be sufficient to target an unrelated protein to the nucleus. We fused the sequence to the terminus of GFP and then visually assessed the location of the reporter protein. The NAC1 sequence (180-207) fused to GFP accumulated in the nucleus ( Figure 3B ). 'Fourthly', the sequence must directly interact with its putative import receptor importin α, a major carrier of cargo from the cytoplasm into the nucleus. To examine whether NAC1 conformed to this criterion, we examined direct binding in vitro using purified proteins. GST pull-down assays revealed that the sequence directly associated with importin α3/α4, but not with importins α1 or α6 ( Figure 5A and 5D) . Furthermore, replacing the basic residues in the sequence of NAC1 or mutations of the major NLS binding site of importin α3 eliminated the NAC1 and importin α3 binding capacity, thus clarifying that the sequence mediated the interaction. The BTB domain comprises a stretch of ~95-125 amino acids and a protein-protein interaction motif that exists in about 183 genes in the human genome (31) . The sequence and structural analysis predict that proteins containing a BTB domain have a variety of functions and participate in several cellular processes such as cytoskeleton dynamics, ion channel assembly and gating and transcriptional regulation. A large group of proteins in the family also contain C 2 H 2 type ZF DNA-binding motifs and 43 BTB-ZF proteins have been identified in the human genome (31) . Some BTB-ZF proteins are linked mainly to hematological cancers (e.g. ZBTB16/PLZF (32), BCL-6 (33) and ZBTB32/FAZF (34)), and others are associated with solid tumors (e.g. Hic-1 (35), ZBTB7A/Pokemon (36), ZBTB7C/APM-1 (37), GMCL1/GCL (38) and Kaiso (39)). The BTB-ZF protein Kaiso contains a classical monopartite NLS and it directly interacts with mouse importin α2 (note that mouse importin α2 is the orthologue of human importin α1) (40) . The BTB-ZF protein Znf131 reportedly has two monopartite NLSs and it preferentially interacts with importin α3 (41). Although most known BTB proteins predominantly localize in the nucleus, the mechanisms of this process remain largely unknown. We could not identify the NAC1 NLS by a series of in silico searches using such tools as PROSITE or MotifScan and thus conducted a visual examination. One of the authors (SK) recently developed a highly accurate NLS prediction program (cNLS Mapper) that calculates NLS activity scores using activity-based, but not sequence-based, profiles of importin α-dependent NLS (42) . Analysis of human NAC1 using this software provided the correct information, whereas the other NLS prediction programs, PSORT II (http://psort.hgc.jp/form2.html) and PredictNLS (http://cubic.bioc. columbia.edu/cgi/var/nair/resonline.pl), failed to predict the NAC1 NLS. Thus, cNLS Mapper is an informative tool for predicting classical NLS, and it is freely available at http://nls-mapper.iab.keio. ac.jp/cgi-bin/NLS_Mapper_form.cgi. The identification of NLS with nuclear proteins such as the transcriptional repressors is a key step to delineate the molecular dynamics and plasticity underlying various cellular processes. We anticipate that this powerful prediction tool will be useful for laying the foundation for understanding the transcriptional regulation and networks of proteins containing a BTB domain with respect to oncogenic properties.
The BTB domain mediates homodimerization as well as proteinprotein interactions, allowing the recruitment of corepressor complexes (9, 12) . In this respect, studies of functional NAC1 inhibition using a truncated NAC1 with potential dominant-negative activity on NAC1 provided important clues to understanding its putative oncogenic role (1, 6, 7) . Here, we introduced point mutations into the BTB domain using structural information (12) and developed a Y86A mutant of NAC1 with resistance to dimer formation, and found that dimer formation is not committed to the nuclear localization of NAC1 in the presence of the NLS sequence. The point mutant will be a useful tool with which we study how dimer formation contributes to transcriptional regulation and protein-protein interactions associated with oncogenic properties.
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Nuclear localization signal in NAC1
In contrast, a dimerization-dependent NLS of signal transducers and activators of transcription 1 protein has been constructed (43) . In summary, we developed a monoclonal antibody against NAC1. Analyses of cell lines and tissues confirmed that NAC1 is a nuclear protein and that dimer formation is not committed to the nuclear localization of NAC1. We identified a novel site on NAC1 that is conserved across species. This region is sufficient to direct the nuclear import of GFP as it binds importin α3/α4, and mutations in this region abolished such binding. These results indicated that the 183-205 basic region of human NAC1 is a functional NLS. We plan to define the NAC1 consensus DNA-binding sequence for the genome-wide study of NAC1-regulated genes in cells, and to investigate whether its downstream target genes are repressed or activated, and how NAC1 proteins function in the nucleus of cancer cells.
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